Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 52 | 2024 | 258 | 15.920 |
Why?
|
| Nociception | 30 | 2024 | 51 | 13.150 |
Why?
|
| Pain Threshold | 48 | 2022 | 89 | 12.450 |
Why?
|
| Emotions | 30 | 2024 | 133 | 8.160 |
Why?
|
| Reflex | 32 | 2024 | 74 | 8.060 |
Why?
|
| Chronic Pain | 12 | 2022 | 61 | 6.540 |
Why?
|
| Pain Measurement | 47 | 2024 | 166 | 5.550 |
Why?
|
| Spinal Cord | 16 | 2021 | 209 | 5.080 |
Why?
|
| Catastrophization | 9 | 2022 | 15 | 4.100 |
Why?
|
| Nociceptors | 18 | 2019 | 42 | 3.610 |
Why?
|
| Electric Stimulation | 34 | 2024 | 255 | 3.370 |
Why?
|
| Adult | 70 | 2024 | 7740 | 2.560 |
Why?
|
| Affect | 12 | 2020 | 85 | 2.520 |
Why?
|
| Fear | 13 | 2020 | 60 | 2.470 |
Why?
|
| Menstrual Cycle | 8 | 2015 | 24 | 2.320 |
Why?
|
| Nociceptive Pain | 6 | 2021 | 11 | 2.200 |
Why?
|
| Female | 82 | 2024 | 15156 | 2.190 |
Why?
|
| Male | 73 | 2024 | 13491 | 2.060 |
Why?
|
| Humans | 101 | 2024 | 28097 | 2.060 |
Why?
|
| Young Adult | 35 | 2024 | 2733 | 2.000 |
Why?
|
| Neural Inhibition | 6 | 2021 | 47 | 1.890 |
Why?
|
| Fibromyalgia | 7 | 2023 | 13 | 1.870 |
Why?
|
| Sleep Wake Disorders | 4 | 2022 | 65 | 1.670 |
Why?
|
| Electromyography | 16 | 2024 | 175 | 1.620 |
Why?
|
| Oklahoma | 12 | 2022 | 1007 | 1.600 |
Why?
|
| Pain Perception | 3 | 2019 | 17 | 1.580 |
Why?
|
| Dreams | 6 | 2019 | 9 | 1.530 |
Why?
|
| Stress Disorders, Post-Traumatic | 7 | 2019 | 69 | 1.500 |
Why?
|
| Adolescent | 29 | 2024 | 3122 | 1.480 |
Why?
|
| Photic Stimulation | 17 | 2024 | 67 | 1.470 |
Why?
|
| Allostasis | 2 | 2021 | 5 | 1.460 |
Why?
|
| Central Nervous System Sensitization | 2 | 2021 | 5 | 1.390 |
Why?
|
| Anxiety | 7 | 2021 | 149 | 1.350 |
Why?
|
| Life Change Events | 2 | 2021 | 33 | 1.310 |
Why?
|
| Conditioning, Classical | 3 | 2020 | 12 | 1.260 |
Why?
|
| Trigeminal Nerve | 3 | 2019 | 5 | 1.250 |
Why?
|
| Galvanic Skin Response | 15 | 2024 | 19 | 1.230 |
Why?
|
| Sex Offenses | 2 | 2019 | 11 | 1.220 |
Why?
|
| Survivors | 2 | 2019 | 40 | 1.200 |
Why?
|
| Stress, Psychological | 4 | 2022 | 221 | 1.200 |
Why?
|
| Arousal | 10 | 2024 | 38 | 1.150 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 366 | 1.140 |
Why?
|
| Sural Nerve | 8 | 2015 | 11 | 1.040 |
Why?
|
| Sex Characteristics | 7 | 2019 | 172 | 0.990 |
Why?
|
| Blinking | 4 | 2019 | 4 | 0.970 |
Why?
|
| Indians, North American | 5 | 2020 | 520 | 0.970 |
Why?
|
| Biofeedback, Psychology | 2 | 2019 | 8 | 0.940 |
Why?
|
| Premenstrual Dysphoric Disorder | 2 | 2015 | 4 | 0.930 |
Why?
|
| Middle Aged | 27 | 2021 | 7138 | 0.890 |
Why?
|
| Surveys and Questionnaires | 15 | 2016 | 971 | 0.860 |
Why?
|
| Anxiety Disorders | 4 | 2020 | 60 | 0.840 |
Why?
|
| Analgesia | 2 | 2018 | 13 | 0.800 |
Why?
|
| Hyperalgesia | 3 | 2018 | 16 | 0.780 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 634 | 0.770 |
Why?
|
| Anger | 2 | 2019 | 15 | 0.730 |
Why?
|
| Psychological Trauma | 1 | 2021 | 4 | 0.720 |
Why?
|
| Adaptation, Psychological | 3 | 2020 | 122 | 0.720 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 452 | 0.700 |
Why?
|
| Foot | 1 | 2020 | 23 | 0.700 |
Why?
|
| Migraine Disorders | 2 | 2019 | 22 | 0.690 |
Why?
|
| Attention | 2 | 2019 | 90 | 0.690 |
Why?
|
| Pattern Recognition, Visual | 2 | 2020 | 37 | 0.680 |
Why?
|
| Saliva | 3 | 2015 | 96 | 0.680 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2020 | 4 | 0.670 |
Why?
|
| Autonomic Nervous System | 3 | 2018 | 112 | 0.660 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2020 | 22 | 0.660 |
Why?
|
| Pleasure | 1 | 2019 | 9 | 0.660 |
Why?
|
| Placebo Effect | 1 | 2018 | 6 | 0.600 |
Why?
|
| Models, Psychological | 5 | 2012 | 81 | 0.590 |
Why?
|
| Testosterone | 2 | 2015 | 72 | 0.570 |
Why?
|
| Awareness | 2 | 2017 | 16 | 0.570 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2015 | 24 | 0.550 |
Why?
|
| Electroshock | 4 | 2011 | 6 | 0.540 |
Why?
|
| Reaction Time | 5 | 2011 | 94 | 0.510 |
Why?
|
| Motivation | 5 | 2018 | 212 | 0.510 |
Why?
|
| Depressive Disorder | 3 | 2019 | 56 | 0.460 |
Why?
|
| Affective Symptoms | 1 | 2014 | 5 | 0.460 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 24 | 0.440 |
Why?
|
| Ischemia | 4 | 2019 | 83 | 0.440 |
Why?
|
| Brain | 4 | 2017 | 741 | 0.430 |
Why?
|
| Reflex, Startle | 5 | 2014 | 8 | 0.410 |
Why?
|
| Analysis of Variance | 7 | 2011 | 391 | 0.410 |
Why?
|
| Athletes | 1 | 2013 | 70 | 0.410 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2009 | 6 | 0.400 |
Why?
|
| Depression | 5 | 2019 | 216 | 0.400 |
Why?
|
| Breathing Exercises | 1 | 2012 | 2 | 0.400 |
Why?
|
| Respiration | 1 | 2012 | 45 | 0.390 |
Why?
|
| Cognition | 4 | 2021 | 324 | 0.380 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 127 | 0.370 |
Why?
|
| Skin | 5 | 2013 | 149 | 0.360 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2011 | 6 | 0.360 |
Why?
|
| Heart Rate | 6 | 2012 | 379 | 0.350 |
Why?
|
| Meditation | 1 | 2010 | 4 | 0.330 |
Why?
|
| Respiratory Rate | 1 | 2010 | 8 | 0.330 |
Why?
|
| Sex Factors | 4 | 2019 | 466 | 0.330 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 17 | 0.330 |
Why?
|
| Case-Control Studies | 3 | 2019 | 722 | 0.330 |
Why?
|
| Neuropsychological Tests | 6 | 2011 | 243 | 0.300 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 769 | 0.300 |
Why?
|
| Implosive Therapy | 2 | 2019 | 2 | 0.300 |
Why?
|
| Relaxation Therapy | 2 | 2019 | 5 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 547 | 0.300 |
Why?
|
| Imagination | 1 | 2008 | 3 | 0.290 |
Why?
|
| Substance-Related Disorders | 2 | 2006 | 185 | 0.270 |
Why?
|
| Delirium | 1 | 2006 | 13 | 0.260 |
Why?
|
| Hot Temperature | 2 | 2004 | 87 | 0.260 |
Why?
|
| Cues | 1 | 2006 | 40 | 0.260 |
Why?
|
| Individuality | 3 | 2015 | 19 | 0.250 |
Why?
|
| Pain Management | 1 | 2006 | 58 | 0.250 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 134 | 0.250 |
Why?
|
| Referral and Consultation | 1 | 2006 | 97 | 0.250 |
Why?
|
| Statistics as Topic | 3 | 2012 | 79 | 0.250 |
Why?
|
| Sleep | 3 | 2021 | 108 | 0.240 |
Why?
|
| Walking | 1 | 2007 | 135 | 0.240 |
Why?
|
| Primary Health Care | 1 | 2007 | 154 | 0.240 |
Why?
|
| Cold Temperature | 2 | 2006 | 34 | 0.240 |
Why?
|
| Risk Factors | 3 | 2021 | 2081 | 0.240 |
Why?
|
| Facial Muscles | 2 | 2019 | 8 | 0.240 |
Why?
|
| Forearm | 2 | 2019 | 39 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 3 | 2011 | 58 | 0.230 |
Why?
|
| Fingers | 1 | 2004 | 16 | 0.230 |
Why?
|
| Body Temperature | 1 | 2004 | 30 | 0.230 |
Why?
|
| Progesterone | 2 | 2015 | 129 | 0.210 |
Why?
|
| Estradiol | 2 | 2015 | 175 | 0.210 |
Why?
|
| Psychological Tests | 2 | 2015 | 21 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 961 | 0.190 |
Why?
|
| Functional Neuroimaging | 2 | 2018 | 23 | 0.180 |
Why?
|
| Cortical Excitability | 1 | 2020 | 2 | 0.180 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2011 | 98 | 0.170 |
Why?
|
| Anorexia Nervosa | 1 | 2020 | 11 | 0.170 |
Why?
|
| Naltrexone | 2 | 2011 | 19 | 0.170 |
Why?
|
| Feeding and Eating Disorders | 1 | 2020 | 15 | 0.170 |
Why?
|
| Prefrontal Cortex | 1 | 2020 | 80 | 0.170 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 145 | 0.170 |
Why?
|
| Postsynaptic Potential Summation | 1 | 2020 | 2 | 0.170 |
Why?
|
| Narcotic Antagonists | 2 | 2011 | 32 | 0.170 |
Why?
|
| Thermosensing | 1 | 2020 | 3 | 0.170 |
Why?
|
| Aged | 7 | 2010 | 5400 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2019 | 3 | 0.160 |
Why?
|
| Suicidal Ideation | 1 | 2019 | 5 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2022 | 1248 | 0.160 |
Why?
|
| Models, Statistical | 2 | 2011 | 128 | 0.160 |
Why?
|
| Reference Values | 3 | 2011 | 199 | 0.160 |
Why?
|
| Fatigue | 2 | 2022 | 64 | 0.160 |
Why?
|
| Physical Stimulation | 1 | 2019 | 72 | 0.150 |
Why?
|
| Anticipation, Psychological | 1 | 2018 | 10 | 0.150 |
Why?
|
| Acoustic Stimulation | 3 | 2013 | 30 | 0.150 |
Why?
|
| Interoception | 1 | 2017 | 22 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 521 | 0.140 |
Why?
|
| Psychometrics | 2 | 2016 | 121 | 0.140 |
Why?
|
| Mental Health | 1 | 2017 | 99 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 28 | 0.130 |
Why?
|
| Age Factors | 2 | 2011 | 734 | 0.130 |
Why?
|
| Aged, 80 and over | 5 | 2010 | 2021 | 0.130 |
Why?
|
| Veterans | 2 | 2007 | 69 | 0.130 |
Why?
|
| Hand | 1 | 2015 | 26 | 0.120 |
Why?
|
| Time Factors | 2 | 2011 | 1592 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2011 | 2379 | 0.110 |
Why?
|
| Facial Expression | 1 | 2014 | 17 | 0.110 |
Why?
|
| Health Status | 1 | 2014 | 148 | 0.100 |
Why?
|
| Comorbidity | 2 | 2020 | 258 | 0.100 |
Why?
|
| Pressure | 1 | 2013 | 90 | 0.100 |
Why?
|
| Women's Health | 1 | 2013 | 60 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2011 | 271 | 0.100 |
Why?
|
| Relaxation | 1 | 2011 | 2 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 169 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1013 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 474 | 0.090 |
Why?
|
| Night Terrors | 1 | 2011 | 1 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 14 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2011 | 417 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2011 | 210 | 0.090 |
Why?
|
| Premenstrual Syndrome | 1 | 2010 | 2 | 0.080 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 8 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2011 | 170 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 57 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 234 | 0.080 |
Why?
|
| Genotype | 1 | 2011 | 456 | 0.080 |
Why?
|
| Psychophysics | 1 | 2008 | 10 | 0.080 |
Why?
|
| Self-Assessment | 1 | 2008 | 10 | 0.080 |
Why?
|
| Motor Activity | 1 | 2010 | 148 | 0.080 |
Why?
|
| Efferent Pathways | 1 | 2008 | 6 | 0.080 |
Why?
|
| Visual Perception | 1 | 2008 | 45 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2009 | 220 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 36 | 0.070 |
Why?
|
| United States | 1 | 2013 | 2146 | 0.070 |
Why?
|
| Extinction, Psychological | 1 | 2007 | 4 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 202 | 0.070 |
Why?
|
| Nerve Net | 1 | 2008 | 106 | 0.070 |
Why?
|
| Headache Disorders | 1 | 2007 | 3 | 0.070 |
Why?
|
| Defense Mechanisms | 1 | 2007 | 6 | 0.070 |
Why?
|
| Psychology | 1 | 2007 | 19 | 0.070 |
Why?
|
| Internal-External Control | 1 | 2007 | 17 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2008 | 394 | 0.070 |
Why?
|
| Recurrence | 1 | 2008 | 322 | 0.070 |
Why?
|
| Happiness | 1 | 2006 | 7 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2006 | 32 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2006 | 17 | 0.070 |
Why?
|
| Mental Processes | 1 | 2006 | 16 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2006 | 29 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2007 | 167 | 0.060 |
Why?
|
| Reward | 1 | 2006 | 45 | 0.060 |
Why?
|
| Algorithms | 1 | 2009 | 430 | 0.060 |
Why?
|
| Craniocerebral Trauma | 1 | 2006 | 27 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 302 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2006 | 91 | 0.060 |
Why?
|
| Bronchitis | 2 | 1995 | 3 | 0.060 |
Why?
|
| Escape Reaction | 1 | 2005 | 4 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2006 | 104 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2006 | 103 | 0.060 |
Why?
|
| Alcoholism | 1 | 2006 | 119 | 0.060 |
Why?
|
| Hormones | 1 | 2005 | 43 | 0.060 |
Why?
|
| Length of Stay | 1 | 2006 | 229 | 0.060 |
Why?
|
| Bacterial Infections | 2 | 1995 | 56 | 0.060 |
Why?
|
| Dementia | 1 | 2006 | 94 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2005 | 96 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 669 | 0.050 |
Why?
|
| Wit and Humor as Topic | 1 | 2003 | 2 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2003 | 63 | 0.050 |
Why?
|
| Quality of Life | 1 | 2007 | 487 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 819 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2003 | 354 | 0.050 |
Why?
|
| Conservative Treatment | 1 | 2021 | 11 | 0.050 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2020 | 16 | 0.040 |
Why?
|
| Asphyxia | 1 | 2020 | 3 | 0.040 |
Why?
|
| Respiratory System | 1 | 2020 | 13 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2020 | 25 | 0.040 |
Why?
|
| Cefuroxime | 2 | 1995 | 4 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2011 | 612 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 1995 | 208 | 0.040 |
Why?
|
| Attentional Bias | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 134 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 120 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 104 | 0.030 |
Why?
|
| Cephalosporins | 1 | 1995 | 18 | 0.030 |
Why?
|
| Personality | 1 | 2015 | 25 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 33 | 0.030 |
Why?
|
| Prodrugs | 1 | 1995 | 30 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 88 | 0.030 |
Why?
|
| Animals | 1 | 2005 | 10423 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 136 | 0.020 |
Why?
|
| Mississippi | 1 | 2010 | 5 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2010 | 20 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 144 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2010 | 65 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 399 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2007 | 7 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2007 | 26 | 0.020 |
Why?
|
| Clavulanic Acids | 2 | 1995 | 2 | 0.020 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 2 | 1995 | 2 | 0.020 |
Why?
|
| Amoxicillin | 2 | 1995 | 6 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 57 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2005 | 53 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 414 | 0.020 |
Why?
|
| Acute Disease | 2 | 1995 | 155 | 0.010 |
Why?
|
| Students | 1 | 2007 | 196 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2546 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 224 | 0.010 |
Why?
|
| Child | 1 | 1995 | 2242 | 0.000 |
Why?
|